Botensilimab by Agenus for Ovarian Cancer: Likelihood of App

Botensilimab is under clinical development by Agenus and currently in Phase I for Ovarian Cancer.

Related Keywords

Massachusetts , United States , , Globaldata Pharmaceutical Intelligence Center , Ovarian Cancer , Phase Transition Success Rate Model , Heat Shock Protein , Pharmaceutical Intelligence ,